Antiverse, a techbio company designing antibodies for challenging targets, today announced it has added £3.5 M ($4.6 M) to its seed funding. The investment will facilitate the Company’s growth, including appointments to… Read More...
In a recent study published in the journal Science Advances, researchers in the United States used 3D transport-based morphometry (TBM) to identify and visualize brain changes linked to 16p11.2 genetic copy number variation… Read More...
